CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts

Group 1 - CVS Health Corporation is considered one of the best healthcare stocks to buy for 2026, with a price target cut to $95 from $100 while maintaining a Buy rating due to CMS's proposed policies affecting Medicare Advantage plans [1] - Cantor Fitzgerald has reiterated CVS as a preferred stock for Medicare Advantage exposure in 2026, expecting the company to benefit from a favorable regulatory environment [2] - Upcoming catalysts in the Medicare Advantage sector include CMS enrollment data and preliminary MA rate notices, which CVS is well-positioned to benefit from [3] Group 2 - CVS's board approved a quarterly dividend of $0.665 per share, reflecting the company's commitment to its integrated healthcare model [4] - CVS Health integrates retail pharmacies and a major health insurer (Aetna) to provide connected health services, prescriptions, insurance, and wellness programs [4]